National Institute of Mental Health; Notice of Closed Meeting, 42311-42312 [E9-20152]
Download as PDF
Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–D–0346]
Draft Guidance for Industry: Guide to
Minimize Microbial Food Safety
Hazards of Tomatoes; Availability;
Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
The Food and Drug
Administration is correcting a notice
that appeared in the Federal Register of
August 3, 2009 (74 FR 38438). The
document announced the availability of
a draft guidance entitled ‘‘Guidance for
Industry: Guide to Minimize Microbial
Food Safety Hazards of Tomatoes.’’ The
document was published with an
incorrect date for submitting written or
electronic comments on the draft
guidance. This document corrects that
error.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Michelle A. Smith, Center for Food
Safety and Applied Nutrition (HFS–
317), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park,
MD 20740, 301–436–2024.
SUPPLEMENTARY INFORMATION: In FR Doc.
E9–18453, appearing on page 38438 in
the Federal Register of August 3, 2009,
the following correction is made:
1. On page 38438, in the third
column, in the ‘‘DATES’’ section, in the
eighth line, ‘‘October 2, 2009’’ is
corrected to read ‘‘November 2, 2009’’.
Dated: August 17, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–20103 Filed 8–20–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–D–0347]
srobinson on DSKHWCL6B1PROD with NOTICES
Draft Guidance for Industry: Guide to
Minimize Microbial Food Safety
Hazards of Melons; Availability;
Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
SUMMARY: The Food and Drug
Administration is correcting a notice
that appeared in the Federal Register of
August 3, 2009 (74 FR 38437). The
VerDate Nov<24>2008
16:22 Aug 20, 2009
Jkt 217001
document announced the availability of
a draft guidancet entitled ‘‘Guidance for
Industry: Guide to Minimize Microbial
Food Safety Hazards of Melons.’’ The
document was published with an
incorrect date for submitting written or
electronic comments on the draft
guidance. This document corrects that
error.
FOR FURTHER INFORMATION CONTACT:
Willette Crawford, Center for Food
Safety and Applied Nutrition (HFS–
317), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park,
MD 20740, 301–436–1111.
SUPPLEMENTARY INFORMATION: In FR Doc.
E9–18452, appearing on page 38437 in
the Federal Register of Wednesday,
August 3, 2009, the following correction
is made:
On page 38437, in the third column,
in the DATES section, in the eighth line,
‘‘October 2, 2009’’ is corrected to read
‘‘November 2, 2009’’.
Dated: August 17, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–20102 Filed 8–20–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–D–0348]
Draft Guidance for Industry: Guide to
Minimize Microbial Food Safety
Hazards of Leafy Greens; Availability;
Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
SUMMARY: The Food and Drug
Administration is correcting a notice
that appeared in the Federal Register of
August 3, 2009 (74 FR 38439). The
document announced the availability of
a draft guidance entitled ‘‘Guidance for
Industry: Guide to Minimize Microbial
Food Safety Hazards of Leafy Greens.’’
The document was published with an
incorrect date for submitting written or
electronic comments on the draft
guidance. This document corrects that
error.
FOR FURTHER INFORMATION CONTACT:
Amy Green, Center for Food Safety and
Applied Nutrition (HFS–317), Food and
Drug Administration, 5100 Paint Branch
Pkwy., College Park, MD 20740, 301–
436–2025.
SUPPLEMENTARY INFORMATION: In FR Doc.
E9–18451, appearing on page 38439 in
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
42311
the Federal Register of August 3, 2009,
the following correction is made:
1. On page 38439, in the third
column, in the ‘‘DATES’’ section, in the
eighth line, ‘‘October 2, 2009’’ is
corrected to read ‘‘November 2, 2009’’.
Dated: August 17, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–20101 Filed 8–20–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
ARRA Studies Involving Human Embryonic
Stem Cells.
Date: August 28, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852. (Telephone
Conference Call)
Contact Person: David W Miller, PhD,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd, Room 6140, MSC 9608,
Bethesda, MD 20892–9608, 301–443–9734,
millerda@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
E:\FR\FM\21AUN1.SGM
21AUN1
42312
Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 / Notices
Dated: August 13, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–20152 Filed 8–20–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Meeting; Moving Into the
Future—New Dimensions and
Strategies for Women’s Health
Research for the National Institutes of
Health
Notice is hereby given that the Office
of Research on Women’s Health
(ORWH), Office of the Director, National
Institutes of Health, Department of
Health and Human Services, in
collaboration with Northwestern
University’s Feinberg School of
Medicine and Northwestern Memorial
Hospital, will convene a public hearing
and scientific workshop on October 14–
16, 2009, at Northwestern University,
Thorne Auditorium, Arthur Rubloff
Building, Chicago, Illinois.
srobinson on DSKHWCL6B1PROD with NOTICES
Purpose of the Meeting
With rapid advances in science and
wider global understanding of women’s
health and sex/gender contributions to
well-being and disease, the purpose of
the meeting is to ensure that NIH
continues to support cutting-edge
women’s health research that is based
upon the most advanced techniques and
methodologies. The meeting format is
designed to promote an interactive
discussion involving leading scientists,
advocacy groups, public policy experts,
health care providers, and the general
public. The Chicago meeting is the
fourth in a series that will be convened
throughout the Nation to help the
ORWH and NIH move into the next
decade of women’s health research.
As science and technology advance
and fields such as computational
biology demonstrate the power of
interdisciplinary research, it remains
critical for sex and gender factors to be
integrated into broad experimental
methodologies and scientific
approaches across the lifespan.
Biomedical and behavioral research are
also necessary to understand how
cultural, ethnic, and racial differences
influence the causes, diagnosis,
progression, treatment, and outcome of
disease among different populations,
including women of diverse geographic
locations and socioeconomic
backgrounds. Furthermore, the fact that
VerDate Nov<24>2008
16:22 Aug 20, 2009
Jkt 217001
there are health differences among
diverse populations of women remains
a critical area in need of continued
focus and attention.
The ORWH challenges all meeting
attendees to assist the NIH in defining
the women’s health research agenda of
the future by thinking beyond
traditional women’s health issues. The
ORWH and NIH ask meeting
participants to consider creative
strategies to identify areas of research
that are best poised for advancement,
identify innovative ways in which
persistent issues of health and disease
can be addressed, and explore new
horizons of scientific concepts and
investigative approaches. Attention also
needs to be paid to new areas of science
application, new technologies, and
continuing basic science investigations.
Clinical questions that are not currently
the focus of research priorities need to
be considered to ensure that women’s
health research is optimally served and
that the ORWH can continue to provide
leadership for the benefit of women’s
health, nationally and internationally.
Meeting Format
The meeting will consist of public
testimony, scientific panels and seven
concurrent scientific working groups.
Specifically, on October 14, individuals
representing a full spectrum of
organizations interested in biomedical
and behavioral research on women’s
health issues will have an opportunity
to provide public testimony from 2 to 6
p.m. On October 15 and 16, plenary
sessions will focus on the intersection of
health care, public policy, and
biomedical research; on emerging issues
and trends in health care; and on
research paradigms of the future. The
seven concurrent afternoon sessions on
October 15 will focus on a range of
research areas, including preventive
heath and special populations; clinical
trials/research; new technologies,
bioengineering, imaging; genetics/
epigenetics; sex hormones and disease;
neuroscience; and women in science
careers. On October 16, the morning
session will be devoted to reports by the
working group co-chairs regarding the
recommendations emerging from
working group deliberations on the
previous day. The meeting will adjourn
at 12:45 p.m. on October 16.
Public Testimony
The ORWH invites individuals with
an interest in research related to
women’s health to provide written and/
or oral testimony on these topics and/
or on issues related to the sustained
advancement of women in various
biomedical careers. Due to time
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
constraints, only one representative
from an organization or professional
specialty group may give oral testimony.
Individuals not representing an
organized entity but a personal point of
view are similarly invited to present
written and/or oral testimony. A letter
of intent to present oral testimony is
necessary and should be sent
electronically to https://
www.orwhmeetings.com/
movingintothefuture/ or by mail to Ms.
Jory Barone, Educational Services, Inc.,
4350 East-West Highway, Suite 1100,
Bethesda, MD 20814, no later than
October 4, 2009. The date of receipt of
the communication will establish the
order of those selected to give oral
testimony at the October meeting.
Those wishing to present oral
testimony are also asked to submit a
written form of their testimony that is
limited to a maximum of 10 pages,
double spaced, 12 point font, and
should include a brief description of the
organization. Electronic submission to
the above Web site is preferred;
however, for those who do not have
access to electronic means, written
testimony, bound by the restrictions
previously noted and postmarked no
later than October 4, 2009, can be
mailed to Ms. Jory Barone at the above
address. All written presentations must
meet the established page limitations.
Submissions exceeding this limit will
not be accepted and will be returned.
Oral testimony of this material at the
meeting will be limited to no more than
5–6 minutes in length.
Because of time constraints for oral
testimony, testifiers may not be able to
present the complete information as it is
contained in their written form
submitted for inclusion in the public
record for the meeting. Therefore,
testifiers are requested to summarize the
major points of emphasis from the
written testimony, not to exceed 6
minutes of oral testimony. Those
individuals or organizations that have
indicated they will present oral
testimony at the meeting in Chicago will
be notified prior to the meeting
regarding the approximate time for their
oral presentation.
Individuals and organizations wishing
to provide written statements only
should send a copy of their statements,
electronically or by mail, to the above
Web site or address by October 4, 2009.
Written testimony received by that date
will be made available at the October
14–16 meeting. Logistics questions
related to the meeting should be
addressed to Ms. Jory Barone at ESI,
while program-specific questions
should be addressed to Dr. Jody K.
Hirsch at the Feinberg School of
E:\FR\FM\21AUN1.SGM
21AUN1
Agencies
[Federal Register Volume 74, Number 161 (Friday, August 21, 2009)]
[Notices]
[Pages 42311-42312]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20152]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; ARRA Studies Involving Human Embryonic Stem Cells.
Date: August 28, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852. (Telephone Conference
Call)
Contact Person: David W Miller, PhD, Scientific Review Officer,
Division of Extramural Activities, National Institute of Mental
Health, NIH, Neuroscience Center, 6001 Executive Blvd, Room 6140,
MSC 9608, Bethesda, MD 20892-9608, 301-443-9734,
millerda@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.242,
Mental Health Research Grants; 93.281, Scientist Development Award,
Scientist Development Award for Clinicians, and Research Scientist
Award; 93.282, Mental Health National Research Service Awards for
Research Training; 93.701, ARRA Related Biomedical Research and
Research Support Awards, National Institutes of Health, HHS)
[[Page 42312]]
Dated: August 13, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-20152 Filed 8-20-09; 8:45 am]
BILLING CODE 4140-01-P